Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 16 Nov 22 425 Business combination disclosure
- 19 Oct 22 EFFECT Notice of effectiveness
- 18 Oct 22 424B3 Prospectus supplement
- 17 Oct 22 425 Business combination disclosure
-
13 Oct 22 F-4/A Registration of securities (foreign) (amended)
- 3 Oct 22 F-4/A Registration of securities (foreign) (amended)
- 13 Sep 22 F-4/A Registration of securities (foreign) (amended)
- 11 Aug 22 425 Business combination disclosure
- 4 Aug 22 F-4 Registration of securities (foreign)
NAMS similar filings
Filing view
External links
Exhibit 23.7
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement on Amendment No. 3 to Form F-4 of our report dated March 25, 2022 relating to the financial statements of Frazier Lifesciences Acquisition Corporation, which is contained in that Registration Statement. We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ WithumSmith+Brown, PC |
New York, New York |
October 13, 2022 |